Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

NCT00590044 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Ketoacidosis

Interventions

DRUG: insulin glargine+ glulisine
DRUG: NPH + Regular insulin

Sponsor

Emory University

Collaborators

[object Object]